(Q71063283)
Statements
A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients (English)
Brattström C
Tydén G
Säwe J
Herlenius G
Claesson K